CAS 755037-03-7: Regorafenib
Formula:C21H15ClF4N4O3
InChI:InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)
InChI key:InChIKey=FNHKPVJBJVTLMP-UHFFFAOYSA-N
SMILES:O(C=1C=C(C(NC)=O)N=CC1)C2=CC(F)=C(NC(NC3=CC(C(F)(F)F)=C(Cl)C=C3)=O)C=C2
Synonyms:- 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
- 4-[4-[N′-(4-Chloro-3-trifluoromethylphenyl)ureido]-3-fluorophenoxy]pyridine-2-carboxylic acid methylamide
- 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide
- Bay 73-4506
- Regorafenib
- Stivarga
Sort by
Found 13 products.
Regorafenib
CAS:Formula:C21H15ClF4N4O3Color and Shape:White To Off-White SolidMolecular weight:482.824-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide
CAS:Purity:99.0%Color and Shape:SolidMolecular weight:482.82000732421875Ref: 10-F361865
1gTo inquire5gTo inquire10gTo inquire25gTo inquire10mgTo inquire50mgTo inquire100mgTo inquire250mgTo inquire500mgTo inquireRegorafenib
CAS:Controlled ProductApplications It inhibits PDGFR tyrosine kinase with IC50=83nM. It is useful for the treatment of inflammation and as an anti-proliferative agent. Dual action VEGFR & Raf inhibitor. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Leuner, C., et al.: Eur. J. Pharm. Biopharm., 50, 47 (2000),Formula:C21H15ClF4N4O3Color and Shape:Off White PowderMolecular weight:482.82Regorafenib
CAS:Multi-kinase inhibitor; inhibits epoxide hydrolase; antineoplasticFormula:C21H15ClF4N4O3Purity:Min. 95%Color and Shape:White PowderMolecular weight:482.82 g/molRegorafenib
CAS:Formula:C21H15ClF4N4O3Purity:>98.0%(HPLC)Color and Shape:White to Light yellow to Light orange powder to crystalMolecular weight:482.82Regorafenib
CAS:Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor that inhibits RET, C-RAF, VEGFR2, c-Kit, VEGFR1, and PDGFRβ and is orallyFormula:C21H15ClF4N4O3Purity:98% - 99.95%Color and Shape:SolidMolecular weight:482.82Ref: TM-T1792
5mg35.00€10mg51.00€25mg80.00€50mg96.00€100mg144.00€200mg185.00€500mg309.00€1mL*10mM (DMSO)57.00€2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-
CAS:Formula:C21H15ClF4N4O3Purity:98%Color and Shape:SolidMolecular weight:482.8154Ref: IN-DA00ICN3
1g131.00€5g255.00€10g619.00€25gTo inquire10mg30.00€50mg46.00€100mg56.00€250mg69.00€500mg100.00€Regorafenib (1-(4-Chloro-3-(trifluoromethyl)phenyl)urea)trimer
CAS:Controlled ProductFormula:C49H31Cl3F10N8O7Color and Shape:NeatMolecular weight:1140.163Regorafenib N-Beta-D-Glucuronide Sodium Salt
CAS:Controlled ProductApplications Regorafenib N-β-D-Glucuronide Sodium Salt, is a derivative of Regorafenib (R143000); a compound that inhibits PDGFR tyrosine kinase with IC50=83nM. Also useful for the treatment of inflammation and as an anti-proliferative agent. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Leuner, C., et al.: Eur. J. Pharm. Biopharm., 50, 47 (2000)Formula:C27H22ClF4N4O9·NaColor and Shape:NeatMolecular weight:680.92Regorafenib
CAS:Formula:C21H15ClF4N4O3Purity:≥ 98.0% (dried basis)Color and Shape:White to off-white powderMolecular weight:482.82
![2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluoroph…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA00ICN3.jpg&w=3840&q=75)
